Dr Reddys Laboratories (RDY) Cash from Financing Activities (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Cash from Financing Activities of -$79.19 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$61.03 million a year earlier.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Cash from Financing Activities (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Cash from Financing Activities at Dr Reddys Laboratories was -$229.45 million; for FY2026 (ended Mar 31, 2026), it came in at $88 million, down 60.4% from FY2025.
- In prior fiscal years, Dr Reddys Laboratories' Cash from Financing Activities was $222 million in FY2025, -$45 million in FY2024, -$327 million in FY2023 and -$32 million in FY2022.
- The fiscal Q2 2027 figure stands as the lowest quarterly Cash from Financing Activities since fiscal Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | -79.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -79.19 Mn |
| Jun 30, 2026 | -75.18 Mn |
| Sep 30, 2025 | -61.03 Mn |
| Jun 30, 2025 | -14.06 Mn |
| Mar 31, 2025 | -85.11 Mn |
| Dec 31, 2024 | 6.99 Mn |
| Sep 30, 2024 | 192.82 Mn |
| Jun 30, 2024 | 114.37 Mn |
| Mar 31, 2024 | -6.42 Mn |
| Dec 31, 2023 | 63.44 Mn |
| Sep 30, 2023 | -85.11 Mn |
| Jun 30, 2023 | -17.97 Mn |
| Mar 31, 2023 | -52.28 Mn |
| Dec 31, 2022 | 7.10 Mn |
| Sep 30, 2022 | -154.85 Mn |
| Jun 30, 2022 | -140.06 Mn |
| Mar 31, 2022 | 67.79 Mn |
| Dec 31, 2021 | -34.27 Mn |
| Sep 30, 2021 | -97.33 Mn |
| Jun 30, 2021 | 30.66 Mn |
API Access
Dr Reddys Laboratories Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();